These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4288498)

  • 1. Tumor immunity after viral oncolysis.
    Cassel WA; Garrett RE
    J Bacteriol; 1966 Sep; 92(3):792. PubMed ID: 4288498
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of antiviral immunity to oncolysis by Newcastle disease virus in a murine lymphoma.
    Eaton MD; Levinthal JD; Scala AR
    J Natl Cancer Inst; 1967 Dec; 39(6):1089-97. PubMed ID: 6079863
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNITY AND ANTIBODY FORMATION INDUCED BY INTRAPERITONEAL OR SUBCUTANEOUS INJECTION OF KREBS-2 ASCITES TUMOR CELLS TREATED WITH INFLUENZA VIRUS.
    EATON MD; LEVINTHAL JD; SCALA AR; JEWELL ML
    J Natl Cancer Inst; 1965 May; 34():661-72. PubMed ID: 14313824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on viral immunotherapy of ascitic tumors in mice. I. Results of treatment with virus on Ehrlich and S180 ascitic tumor cells].
    Huang ZX; Zhang LB; Jia FL; Peng TC; An HQ; Jiang YZ; Li Y; Cao GR; Duan SX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):213-6. PubMed ID: 6241052
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 6. Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
    Apffel CA; Peters JH
    J Natl Cancer Inst; 1967 Dec; 39(6):1129-39. PubMed ID: 4170428
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of BCG (Romanian substrain) on the Ehrlich carcinoma in A2G mice.
    Piţur I; Ciufecu E; Drăghici D; Andronescu F; Glăvan D
    Arch Roum Pathol Exp Microbiol; 1979; 38(1):95-103. PubMed ID: 546376
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of mice to Sarcoma 180 and Ehrlich carcinoma with ultraviolet-killed tumor vaccine.
    Littman ML; Kim YC; Suk D
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):7-17. PubMed ID: 5657038
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
    Nakashima Y
    Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the action of an immunostimulin associated with anaerobic Corynebacteria in human and experimental neoplasms].
    Halpern B; Israel L
    C R Acad Hebd Seances Acad Sci D; 1971 Nov; 273(22):2186-90. PubMed ID: 5003089
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
    D'Alessandro G; Giammanco G; Barncato P
    Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex differences in tumour growth and lymphoid reactions in mice with Ehrlich's ascites carcinoma.
    Thunold S
    Acta Pathol Microbiol Scand; 1967; 69(4):521-33. PubMed ID: 6031366
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
    Lapointe JR; Portelance V
    Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
    Saha S; Mondal S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth of Erlich tumors in Swiss mice by diphtheria toxin.
    Buzzi S; Maistrello I
    Cancer Res; 1973 Oct; 33(10):2349-53. PubMed ID: 4741933
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.
    Lindenmann J; Klein PA
    J Exp Med; 1967 Jul; 126(1):93-108. PubMed ID: 4290961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.